|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
8 June 2015 |
|
Main ID: |
NCT02012595 |
|
Date of registration:
|
26/11/2013 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
[11C]Donepezil PET For Imaging The Autonomous Nervous System In Parkinsons Disease
|
|
Scientific title:
|
[11C]Donepezil PET For Imaging The Autonomous Nervous System In Parkinsons Disease |
|
Date of first enrolment:
|
October 2013 |
|
Target sample size:
|
24 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT02012595 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Case Control, Time Perspective: Cross-Sectional
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Denmark
| | | | | | | |
|
Contacts
|
|
Name:
|
Per Borghammer, MD, PhD,DMSc |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Dept. of Nuclear Medicine & PET Center, Aarhus University Hospital, Aarhus, Denmark |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Age 40-80 years
Exclusion Criteria:
- dementia,
- psychiatric diseases,
- serious medical illness including any type of previous cancer
- any drug with known interaction with the autonomic nervous system
- metal in the body (because of MRI scan)
- pregnancy or breast feeding (because of radiation due to PET/CT)
- known diseases of the salivary glands, stomach, intestines.
- Prior major surgery to salivary glands, esophagus, stomach.
Age minimum:
40 Years
Age maximum:
80 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Parkinson's Disease
|
|
Intervention(s)
|
|
Other: [11C]donepezil PET
|
|
Primary Outcome(s)
|
|
Distribution volume of [11C]donepezil in internal organs
[Time Frame: The distribution volume of [11C]donepezil is measured at "Day 1" by PET/CT scanning each participant. The data analysis is done when all participants have completed the study.]
|
|
Secondary ID(s)
|
|
2013-003775-35
|
|
2013-01
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|